ERNDIMQA - Neurotransmitters in CSF
Purpose: |
Comparison of Neurotransmitter metabolite outcome in a lab in respect to median and target values |
Scientific Expert: |
Dr Simon Pope simon.pope@uclh.nhs.uk |
Scheme Organiser: |
Dr. E. van der Hagen e-mail: E.vanderhagen@skbwinterswijk.nl |
Analytes: |
Homovanillic acid (HVA), 5-hydroxyindole acetic acid (5-HIAA), 3-methyl dopa (3-MD) and 5-hydroxytryptophan (5-HTTP), HVA:5-HIAA ratio |
Number of Specimens/Year: |
8 |
Matrix of the Specimens: |
A mixture of spiked/diluted lyophilised cerebrospinal spinal fluid (CSF) and artifical CSF |
Volume/Specimen: |
500µl/vial |
Number of Shipments/Year: |
One shipment of 8 specimens in February |
Submission of Results: |
Via ERNDIM Interactive Website |
Reports: |
Requested from ERNDIM Interactive Website |
Certificate: |
Once a year issued by ERNDIM Board |
Number of Participants: |
34 (2019) |
Status of the Scheme: |
Pilot scheme in 2014-2015, full scheme from 2016 |
Geographic Area: |
Worldwide |
Limitation Participation: |
None |
Cost/Year: |
391 EURO (2021) |
How to subscribe: |
e-mail: admin@erndim.org |
|
Click here for Annual Reports |